In their study of OSCC in Taiwan, Lin et al. found no significant correlation between survivin expression and patient age, gender, oral habits, cancer location, or TNM status, but the patients with high survivin expression, an advanced stage, a larger tumour size or positive lymph node metastases had a significantly shorter OS than the others (P = .014, .012, .005, and .011, log-rank test) [137]. The gene discussed is BIRC5; the disease is neoplasm.